Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Prostate Cancer and Prostatic Diseases|October 2, 2023
Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare populationStephen J Freedland, Matthew Davis, Andrew J Epstein, et al.Plos One|January 5, 2017
Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational StudySheila Weinmann, Allison Naleway, Geeta Swamy, et al.Advances in Therapy|August 2, 2023
Healthcare Costs in Men with Metastatic Castration-Resistant Prostate Cancer: An Analysis of US Medicare Fee-For-Service ClaimsStephen J Freedland, Matthew R Davis, Andrew J Epstein, et al.Melanoma Research|June 14, 2014
Economic burden of brain metastases among patients with metastatic melanoma in a USA managed care populationFrancis Vekeman, Michel Cloutier, Sander Yermakov, et al.Journal of Cancer Research and Clinical Oncology|December 2, 2020
Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a real-world retrospective observational studyEric Nadler, Bhakti Arondekar, Kathleen Marie Aguilar, et al.Advances in Therapy|November 5, 2022
Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in the United States, Europe, and IsraelReshma Mahtani, Alexander Niyazov, Katie Lewis, et al.Cancer|June 1, 2021
The value of new drugs for advanced prostate cancerDavid H Howard, Ruben G W Quek, Kathleen M Fox, et al.Journal of Managed Care & Specialty Pharmacy|August 2, 2021
Payer perceptions of the use of real-world evidence in oncology-based decision makingDiana Brixner, Joseph Biskupiak, Gary Oderda, et al.BMC Cancer|December 22, 2022
Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2-negative advanced breast cancer from the United States, Europe, and IsraelReshma Mahtani, Alexander Niyazov, Bhakti Arondekar, et al.Plos One|February 12, 2015
Pregnancy after treatment for cervical cancer precursor lesions in a retrospective matched cohortAllison L Naleway, Sheila Weinmann, Girishanthy Krishnarajah, et al.Pageof 5